Following the release of the redesigned Advantage BX software for isokinetic systems in 2020, Biodex Medical Systems Inc, part of Mirion Technologies) further improves the user experience with its latest enhancements, designed to simplify test results for common, often costly, hamstring injuries.
These new simplified reports help make it easier for clinicians to understand and communicate test protocols and their impact on a return-to-play decision.
To facilitate easier communication to everyone involved in the return-to-play (RTP) decision – from the athlete to the referring physician – the return-to-play reports in the latest software release show clear pass/fail results of tests based on established targeted outcomes. By helping stakeholders see the value of objective testing and its impact on establishing readiness for returning to play, clinics may increase their physician referrals as well as elevate the patient experience, Biodex explains in a media release.
The hamstring RTP reports are one of many updates issued with the latest release designed to help improve the Biodex System 4’s usability. Other enhancements include linked protocols that seamlessly guide clinicians through rehab or testing sessions, a quick start function to easily repeat favorite activities, and improved data management for clinical research.
“Advantage BX software is all about an enhanced user experience with the Biodex System 4. We are very excited about the latest release because it not only closes the gap of certain features that were in the legacy software, but it does so with improved functionality and presentation of those features.”
— Ed Behan, Senior VP of the Physical Medicine Sales Division at Biodex
[Source(s): Biodex Medical Systems, PRWeb]
Related Content:
Biodex is Now Part of Mirion Technologies
Biodex Software Now Includes Return-to-Play Report
Biodex Releases Redesigned Software for the System 4 Dynamometer
